BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8096495)

  • 21. The relationship among apolipoprotein(a) polymorphisms, the low-density lipoprotein receptor-related protein, and the very low density lipoprotein receptor genes, and plasma lipoprotein(A) concentration in the Czech population.
    Benes P; Muzík J; Benedík J; Znojil V; Vácha J
    Hum Biol; 2002 Feb; 74(1):129-36. PubMed ID: 11931574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of the low density lipoprotein receptor gene PvuII intron 15 polymorphism using the polymerase chain reaction: association with plasma lipid traits in healthy men and women.
    Gudnason V; Zhou T; Thormar K; Baehring S; Cooper J; Miller G; Humphries SE; Schuster H
    Dis Markers; 1998 Feb; 13(4):209-20. PubMed ID: 9553735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of low-density lipoprotein buoyant density and cholesterol content on the formation of lipoprotein(a) particles.
    Becker L; Gabel BR; Spencer CA; Marcovina SM; Koschinsky ML
    Clin Exp Med; 2001 Jun; 1(2):121-5. PubMed ID: 11699729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The fractional catabolic rate of low density lipoprotein in normal individuals is influenced by variation in the apolipoprotein B gene: a preliminary study.
    Houlston RS; Turner PR; Revill J; Lewis B; Humphries SE
    Atherosclerosis; 1988 May; 71(1):81-5. PubMed ID: 2897860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia.
    Bredie SJ; Vogelaar JM; Demacker PN; Stalenhoef AF
    Atherosclerosis; 1996 Oct; 126(2):313-24. PubMed ID: 8902157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
    Ginsberg HN; Le NA; Gibson JC
    J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low density lipoprotein cholesterol, lipoprotein(a), and apo(a) isoforms in the elderly: relationship to fasting insulin. Associazione Medica Sabin.
    Carantoni M; Zuliani G; Bader G; Palmieri E; Volpato S; Passaro A; Imbastaro T; Mezzetti A; Fellin R
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):228-33. PubMed ID: 10656169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidation of lipoprotein(a) and low density lipoprotein containing density gradient ultracentrifugation fractions.
    Kleinveld HA; Duif PF; Pekelharing HL; van Rijn HJ
    Biochim Biophys Acta; 1996 Sep; 1303(1):15-21. PubMed ID: 8816848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA polymorphisms at the lipoprotein lipase gene and their association with quantitative variation in plasma high-density lipoproteins and triacylglycerides.
    Mitchell RJ; Earl L; Bray P; Fripp YJ; Williams J
    Hum Biol; 1994 Jun; 66(3):383-97. PubMed ID: 8026810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of apolipoprotein E polymorphism on plasma lipoprotein(a) levels.
    Horita K; Eto M; Saito M; Nakata H; Iwashima Y; Ito H; Takahashi M; Kondo A; Morikawa A; Makino I
    Artery; 1993; 20(6):324-36. PubMed ID: 8010888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LDL-unbound apolipoprotein(a) and carotid atherosclerosis in hemodialysis patients.
    Kronenberg F; Trenkwalder E; Sturm W; Kathrein H; König P; Neyer U; Gröchenig E; Utermann G; Dieplinger H
    Clin Genet; 1997 Nov; 52(5):377-86. PubMed ID: 9520130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjects.
    Knight BL; Perombelon YF; Soutar AK; Wade DP; Seed M
    Atherosclerosis; 1991 Apr; 87(2-3):227-37. PubMed ID: 1830206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.
    Rader DJ; Mann WA; Cain W; Kraft HG; Usher D; Zech LA; Hoeg JM; Davignon J; Lupien P; Grossman M
    J Clin Invest; 1995 Mar; 95(3):1403-8. PubMed ID: 7883987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Physiology and pathophysiology of the metabolism of lipoproteins].
    Sandhofer F
    Wien Med Wochenschr; 1994; 144(12-13):286-90. PubMed ID: 8650930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of LDL receptor gene marker associated with altered levels of LDL cholesterol and apolipoprotein B in baboons.
    Hixson JE; Kammerer CM; Cox LA; Mott GE
    Arteriosclerosis; 1989; 9(6):829-35. PubMed ID: 2574032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LDL physical properties, lipoprotein and Lp(a) levels in acromegalic patients. Effects of octreotide therapy. Italian Multicenter Octreotide Study Group.
    Arosio M; Sartore G; Rossi CM; Casati G; Faglia G; Manzato E
    Atherosclerosis; 2000 Aug; 151(2):551-7. PubMed ID: 10924734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy?
    Kronenberg F; Lingenhel A; Lhotta K; Rantner B; Kronenberg MF; König P; Thiery J; Koch M; von Eckardstein A; Dieplinger H
    Kidney Int; 2004 Jul; 66(1):348-54. PubMed ID: 15200443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels.
    Kroon AA; van't Hof MA; Demacker PN; Stalenhoef AF
    Atherosclerosis; 2000 Oct; 152(2):519-26. PubMed ID: 10998482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The susceptibility of lipoprotein(a) to copper oxidation is correlated with the susceptibility of autologous low density lipoprotein to oxidation.
    Nakajima K; Yamashita T; Kusuhara M; Yonemura A; Ito T; Higashi K; Ayaori M; Ohmori R; Nakamura H; Ohsuzu F
    Clin Biochem; 2003 Mar; 36(2):113-20. PubMed ID: 12633760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.